Title : Oncogene-targeted antisense oligodeoxynucleotides combined with chemotherapy or immunotherapy: a new approach for tumor treatment?

Pub. Date : 1994

PMID : 8026602






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Synthetic oligodeoxynucleotides (antisenses) complementary to bcr/abl breakpoint junction transcript on Philadelphia chromosome, or c-myb protooncogene inhibit partially the proliferation of Philadelphia positive leukemic cells (antisenses against bcr/abl and c-myb) and other tumor cells (antisenses against c-myb). Oligodeoxyribonucleotides ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens
2 Synthetic oligodeoxynucleotides (antisenses) complementary to bcr/abl breakpoint junction transcript on Philadelphia chromosome, or c-myb protooncogene inhibit partially the proliferation of Philadelphia positive leukemic cells (antisenses against bcr/abl and c-myb) and other tumor cells (antisenses against c-myb). Oligodeoxyribonucleotides ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens